第1页å‚è§é™„ä»¶(147KB,2页)。
[摘è¦]目的 对术å‰ä¸æ˜ŽåŽŸå› çš„çŽ»ç’ƒä½“æ··æµŠç—…ä¾‹åˆ‡å‰²æœ¯åŽè¿›è¡Œç—…å› åˆ†æžï¼Œä¸ºæ¤ç±»ç–¾ç—…的处置作一些有益探索。 方法 回顾性分æžè¿‘3年接å—玻璃体切割手术治疗的45例䏿˜ŽåŽŸå› çŽ»ç’ƒä½“æ··æµŠæ‚£è€…çš„ä¸´åºŠèµ„æ–™ï¼Œå¯¹æœ¯ä¸åŠæœ¯åŽæ‰€èŽ·å¾—çš„æœ‰å…³ç—…å› ä¿¡æ¯è¿›è¡Œå½’纳剖æžã€‚ 结果 在本组玻璃体混浊接å—玻璃体切割手术的患者ä¸ï¼Œè€å¹´æ‚£è€…以视网膜é™è„‰é˜»å¡žå’Œä¸æ˜ŽåŽŸå› å¤šè§;年轻患者以é™è„‰ç‚Žã€è¿‘视多è§ã€‚ 结论 è€å¹´æ‚£è€…æ— æ˜Žç¡®ç—…å› çš„çŽ»ç’ƒä½“æ··æµŠåº”å°½æ—©è¡ŒçŽ»ç’ƒä½“åˆ‡å‰²æœ¯ï¼Œä»¥åˆ©äºŽæ‚£è€…è§†åŠ›çš„å°½æ—©æ¢å¤ï¼Œæœ‰åŠ©äºŽé˜²æ¢å¹¶å‘症的å‘生。
[关键è¯] 玻璃体混浊;ç—…å› å¦;玻璃体切割术
Primary study on etiological factors of unidentified vitreous
opacity after vitrectomy
WANG Ai-lian,LIU Yao
(Department of Ophthalmology,Zhongda Hospital,Southeast University,Nanjing210009,China)
Abstract:Objective To explore etiological factors of unidentified vitreous opacity after vitrectomy and helpful therapy.Methods In a period of three years,45cases with unidentified vitreous opacity were analyzed retrospec-tively and information about etiological factors during and after operation were collected.Results Retinal vein oc-clusion and unidentified etiological factors in the old ages were common;while Eales's disease and myopia in young people.Conclusion Vitrectomy should be performed early in the elderly patients with unknown etiological factors in order to restore visual acuity early and prevent complications.
Key words:vitreous opacity;etiology;vitrectomy
å¾ˆå¤šåŽŸå› å¦‚å‡ºè¡€ã€ç‚Žç—‡ã€å˜æ€§ã€è‚¿ç˜¤ç‰éƒ½å¯å¼•起玻璃体混浊。以往对于玻璃体混浊疾病,多强调ä¿å®ˆæ²»ç–—çš„é‡è¦æ€§ï¼Œè‡´ä½¿æ‚£è€…的视力难以æ¢å¤ï¼Œä¸ä»…严é‡å½±å“患者的生活质é‡ï¼Œè€Œä¸”å¾ˆå¤šç—…ä¾‹å› ä¸èƒ½åŠæ—¶å¯¹å‘ç—…åŽŸå› è¿›è¡Œå¤„ç†è€Œäº§ç”Ÿè¯¸å¦‚新生血管性é’光眼ç‰ä¸¥é‡å¹¶å‘ç—‡ï¼Œé€ æˆæ°¸ä¹…性视功能æŸå®³ã€‚è¿‘å¹´æ¥ï¼Œéšç€çŽ»ç’ƒä½“æ‰‹æœ¯æŠ€æœ¯æˆç†Ÿï¼Œå°¤å…¶æ˜¯25G微创玻璃体手术的开展[1] ï¼ŒçŽ»ç’ƒä½“æ‰‹æœ¯å·²ç»æˆä¸ºçœ¼ç§‘å¸¸è§„æ‰‹æœ¯ä¹‹ä¸€ã€‚å› æ¤ï¼Œä½œè€…å›žé¡¾åˆ†æžæœ¬é™¢è¿‘3å¹´æ¥è¡ŒçŽ»ç’ƒä½“åˆ‡å‰²æ‰‹æœ¯æ²»ç–—ä¸æ˜ŽåŽŸå› çŽ»ç’ƒä½“æ··æµŠæ‚£è€…çš„ä¸´åºŠèµ„æ–™ï¼Œå‚考术ä¸åŠæœ¯åŽçœ¼åº•镜检查ã€è§å…‰é€ 影检查所è§ï¼Œå¯¹ç—…å› æž„æˆè¿›è¡Œåˆ†æžï¼Œå¸Œæœ›
借æ¤å¯¹ä¸æ˜ŽåŽŸå› çŽ»ç’ƒä½“æ··æµŠæ‰‹æœ¯æ—¶æœºçš„é€‰æ‹©æä¾›å‚ 考。
1 临床资料
1.1 一般资料
本组病例共45例45åªçœ¼ï¼Œå…¶ä¸ç”·33例,女12例;年龄14~88å²ï¼Œå¹³å‡60å²;病程2周~3年。术å‰B超检查示åˆå¹¶è§†ç½‘膜脱离2例,åˆå¹¶å¹¶å‘性白内障åŠè€å¹´æ€§ç™½å†…éšœ10例。术å‰å¸¸è§„行视力ã€å…‰å®šä½ã€è‰²è§‰ã€çœ¼éƒ¨Bè¶…åŠæ£€çœ¼é•œæ£€æŸ¥ï¼Œå…¨èº«æ£€æŸ¥åŒ…括血生化常规ã€è¡€å¸¸è§„ã€ç©ºè…¹åŠé¤åŽè¡€ç³–ã€è¡€åŽ‹ã€å¿ƒç”µå›¾ç‰ã€‚
1.2 方法
所有病例å‡è¡Œç»æ‰å¹³éƒ¨é—åˆå¼ä¸‰åˆ‡å£çŽ»ç’ƒä½“åˆ‡é™¤æœ¯ï¼Œæœ¯ä¸æ— 论ä¿å˜æ™¶ä½“与å¦å‡å°½é‡åˆ‡é™¤å‘¨è¾¹éƒ¨çŽ»ç’ƒä½“ï¼Œå¯¹æœ‰è§†ç½‘è†œæ˜Žæ˜¾å˜æ€§åŒºæˆ–为视网膜é™è„‰é˜»å¡žã€é™è„‰ç‚Žè€…术ä¸è¡Œçœ¼å†…激光治疗,åˆå¹¶è§†ç½‘è†œè„±ç¦»è€…åŒæ—¶è¡Œè§†ç½‘膜å¤ä½æœ¯ï¼Œåˆå¹¶ç™½å†…éšœè€…åŒæ—¶è¡Œç™½å†…éšœæ‘˜é™¤æœ¯ã€‚éƒ¨åˆ†æ‚£è€…æ‰‹æœ¯ç»“æŸæ—¶ç»™äºˆç©ºæ°”æˆ–æ··åˆæ°”ä½“çŽ»ç’ƒä½“è…”å†…å¡«å……ï¼Œæœ¯ä¸æœªå‘çŽ°æ˜Žç¡®æ··æµŠåŽŸå› è€…æœ¯åŽå‡äºˆçœ¼åº•è§å…‰é€ å½±æ£€æŸ¥ï¼Œä»¥è¿›ä¸€æ¥æ˜Žç¡®ç—…å› ã€‚
2 结 果
术ä¸åŠæœ¯åŽå‘现,本组病例ä¸è§†ç½‘膜é™è„‰é˜»å¡žåŠä¸æ˜ŽåŽŸå› æ‰€å æ¯”例最多,而åŽä¾æ¬¡ä¸ºé«˜è¡€åŽ‹åŠ¨è„‰ç¡¬åŒ–ã€è‘¡è„膜炎ã€é»„æ–‘å˜æ€§ã€é™è„‰ç‚Žã€è¿‘视。è€å¹´æ‚£è€…(>50å²)以é™è„‰é˜»å¡žã€ä¸æ˜ŽåŽŸå› 2ç§åŽŸå› å¤šè§;年轻患者以é™è„‰ç‚Žã€è¿‘视多è§ã€‚å…·ä½“ç—…å› æž„æˆè§ä¸‹è¡¨ã€‚表1 çŽ»ç’ƒä½“æ··æµŠæ‚£è€…ç—…å› æž„æˆåŠå¹´é¾„情况表(ç•¥)
3 讨 论
玻璃体的混浊å¯ç”±å¤šç§åŽŸå› å¯¼è‡´ï¼Œæ˜¯ä¸¥é‡å½±å“视力的é‡è¦ç–¾ç—…之一,常规给予ä¿å®ˆæˆ–æ‰‹æœ¯æ²»ç–—ã€‚ä»¥å¾€ç”±äºŽçŽ»ç’ƒä½“æ‰‹æœ¯æŠ€æœ¯ç›¸å¯¹å¤æ‚,且有一定手术风险,对于æ¤ç±»ç–¾ç—…多强调ä¿å®ˆæ²»ç–—,ä¿å®ˆæ²»ç–—3~6ä¸ªæœˆè§†åŠ›æ— æ˜Žæ˜¾å¥½è½¬åŽæ‰å»ºè®®æ‰‹æœ¯æ²»ç–—ã€‚æ¤æ—¶æ‚£è€…的视力ä¸ä»…长时间难以æ¢å¤ï¼Œè€Œä¸”å¾ˆå¤šæ‚£è€…å› ä¸èƒ½åŠæ—¶æ˜Žç¡®ç—…å› å¹¶å¯¹å…¶è¿›è¡Œå¤„ç†ï¼Œäº§ç”Ÿè¯¸å¦‚新生血管性é’光眼ã€å¹¶å‘性白内障ç‰ä¸¥é‡å¹¶å‘ç—‡ï¼Œéƒ¨åˆ†æ‚£è€…ç”šè‡³é€ æˆæ°¸ä¹…性视功能æŸå®³ã€‚
æœ¬ç ”ç©¶æ˜¾ç¤ºï¼Œ50å²ä»¥ä¸Šçš„æ‚£è€…,其玻璃体混浊由é™è„‰é˜»å¡žå¼•起者å 31.1%,其次是高血压动脉硬化(15.5%)ã€è‘¡è„膜炎(8.9%)ã€è€å¹´é»„æ–‘å˜æ€§(4.4%)。视网膜é™è„‰é˜»å¡žå¯å¯¼è‡´è§†åЛ䏥é‡å—æŸï¼Œç—…程较长。黄斑水肿ã€è§†ä¹³å¤´åŠè§†ç½‘膜新生血管是常è§å¹¶å‘症,也是致盲的é‡è¦åŽŸå› ã€‚å°¤å…¶æ˜¯ç¼ºè¡€åž‹æ‚£è€…ï¼Œå…¶ç—…å˜åŒºåŸŸè§† ç½‘è†œæ¯›ç»†è¡€ç®¡å¹¿æ³›æ— çŒæ³¨ï¼ŒåŠ ä¹‹çŽ»ç’ƒä½“ç§¯è¡€ï¼Œä¼šå¼•èµ·å¢žæ®–æ€§çŽ»ç’ƒä½“è§†ç½‘è†œç—…å˜ã€è§†ç½‘膜脱离ã€è™¹è†œçº¢å˜ã€æ–°ç”Ÿè¡€ç®¡æ€§é’光眼ç‰å¹¶å‘症,最终导致患者视功能的丧失。玻璃体切除术能彻底清除病å˜çŽ»ç’ƒä½“ï¼Œä»Žè€Œæ¸…é™¤çŽ»ç’ƒä½“ä¸å¤§é‡å˜åœ¨çš„ç‚Žç—‡å› å和血管生æˆå› å,阻æ¢å¢žæ®–性玻璃体视网膜病å˜è¿›ä¸€æ¥å‘展[2] ;å¦å¤–,玻璃体切除使术ä¸ã€æœ¯åŽæ¿€å…‰æ²»ç–—æˆä¸ºå¯èƒ½ï¼Œä»Žè€Œèƒ½å¤Ÿæœ‰æ•ˆé˜²æ¢è™¹è†œçº¢å˜ã€æ–°ç”Ÿè¡€ç®¡æ€§é’光眼ç‰å¹¶å‘ç—‡ã€‚å› æ¤ï¼Œå°½æ—©è¡Œæ‰‹æœ¯å¹²é¢„对控制疾病进程有é‡è¦æ„义。近年æ¥ï¼Œéšç€çŽ»ç’ƒä½“æ‰‹æœ¯æŠ€æœ¯çš„æˆç†Ÿï¼Œå°¤å…¶æ˜¯25Gå¾®åˆ›çŽ»ç’ƒä½“æ‰‹æœ¯çš„å¼€å±•ï¼ŒçŽ»ç’ƒä½“æ‰‹æœ¯å·²ç»æˆä¸ºçœ¼ç§‘å¸¸è§„æ‰‹æœ¯ä¹‹ä¸€ï¼Œå› çŽ»ç’ƒä½“åˆ‡å‰²æœ¯æœ¬èº«æ‰€å¯¼è‡´çš„å¹¶å‘ç—‡é€æ¸å‡å°‘。国外å¦è€…ä¹Ÿä¸»å¼ è§†ç½‘è†œé™è„‰é˜»å¡žå¼•起的玻璃体混浊应在视网膜玻璃体增殖ã€è§†ç½‘膜脱离出现以å‰å°½æ—©è¡ŒçŽ»ç’ƒä½“åˆ‡å‰²æœ¯ï¼Œä»¥èŽ·å¾—æ›´å¥½çš„è§†åŠ›[3] ã€‚çŽ»ç’ƒä½“åˆ‡å‰²åŒæ—¶è¡Œå¢žæ®–膜分离ã€t.PA注射ã€å‘¨è¾¹è§†ç½‘膜光å‡å¯¹è§†ç½‘膜é™è„‰é˜»å¡žçš„æ²»ç–—是有效的[4] 。å¦å¤–,我们认为,对于è€å¹´æ‚£è€…ä¸ç”±é«˜è¡€åŽ‹ã€åŠ¨è„‰ç¡¬åŒ–ã€è‘¡è„膜炎åŠé»„æ–‘å˜æ€§ç‰å¼•èµ·çš„çŽ»ç’ƒä½“æ··æµŠï¼Œå°½æ—©æ‰‹æœ¯ä¹Ÿèƒ½å¤Ÿå°½å¿«æ˜Žç¡®ç—…å› ï¼Œä¸ºç—…å› æ²»ç–—åˆ›é€ æ¡ä»¶ã€‚å› æ¤ï¼Œå¯¹è€å¹´æ‚£è€…䏿˜ŽåŽŸå› çŽ»ç’ƒä½“å‡ºè¡€æ‰€è‡´çŽ»ç’ƒä½“æ··æµŠï¼Œåº”å°½æ—©æ‰‹æœ¯æ²»ç–—ï¼Œæ ¹æ®æœ¯ä¸çœ¼åº•ç—…å˜åŠæœ¯åŽçœ¼åº•è§å…‰é€ 影明确诊æ–ï¼Œé’ˆå¯¹ç—…å› è¿›ä¸€æ¥æ²»ç–—,尽å¯èƒ½é˜²æ¢ä¸¥é‡å¹¶å‘ç—‡å‘ç”Ÿã€‚æœ¬ç»„å¹´è½»æ‚£è€…è¾ƒå°‘ï¼Œç»“æžœéš¾ä»¥è¯´æ˜Žé—®é¢˜ï¼Œæœ‰å¾…ä¸´åºŠä¸Šè¿›ä¸€æ¥æ€»ç»“ç ”ç©¶ã€‚
[å‚考文献]
[1]FUJII G Y,de JUAN E Jr,HUMAYUM M S.A new25.gauge in-strument system for transconjunctival sutureless vitrectomy surgery [J].Ophthalmology,2002,109:1807.1813.
[2]æŽå…‰è¾‰.玻璃体视网膜出血性疾病的远期疗效观察[J].ä¸å›½å®žç”¨çœ¼ç§‘æ‚志,1999,17:540.541.
[3]TANAKA M,NINOMIYA H,KOBAYASHI Y,et al.Studies on vit-rectomy cases associated with complicated branch retinal vein occlu-sion[J].Jpn J Ophthalmol,2001,45:397.402.
[4]LAMH D,BLUMENKRANZ M S.Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions,subretinal peripapillary tissue plasminogen activator in-jection,and photocoagulation [J].Am J Ophthalmol,2002,134: 609.611.
(东å—大å¦é™„属ä¸å¤§åŒ»é™¢çœ¼ç§‘,江è‹å—京 210009)
http://www.100md.com/html/paper/1671-7562/2005/01/06.htm
您现在查看是摘è¦ä»‹ç»é¡µï¼Œè¯¦è§PDF附件(147KB,2页)。
